Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy

Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy

Item
http://www.wikidata.org/entity/Q37117624
Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological MalignancyEarly Emergence of CD19-Negative Human Antibody-Secreting Cells at the Plasmablast to Plasma Cell Transition.Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens.CD19-Targeted CAR T cells as novel cancer immunotherapy for relapsed or refractory B-cell acute lymphoblastic leukemia.Donor origin CAR T cells: graft versus malignancy effect without GVHD, a systematic review.Antibody-secreting plasma cells persist for decades in human intestine.To B or not to B maintained?Recurrent urinary tract infections and low secretory IgA following CD19-directed CAR T-cell therapy for relapsed acute lymphoblastic leukemia.Anti-CD123 chimeric antigen receptor T-cells (CART): an evolving treatment strategy for hematological malignancies, and a potential ace-in-the-hole against antigen-negative relapse.Plasma cell survival in the absence of B cell memory.Building a Safer and Faster CAR: Seatbelts, Airbags, and CRISPR.The Evolution and Future of CAR T Cells for B-Cell Acute Lymphoblastic Leukemia.An APRIL based chimeric antigen receptor for dual targeting of BCMA and TACI in Multiple Myeloma.The Pharmacology of T Cell Therapies.Plasma Cell Differentiation Pathways in Systemic Lupus Erythematosus.B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets.Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation.
P2860

Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy

Item
http://www.wikidata.org/entity/Q37117624
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Persistence of long-lived plas ...... 19-directed CAR T-cell therapy
@en
Persistence of long-lived plas ...... 9-directed CAR T-cell therapy.
@nl
type
label
Persistence of long-lived plas ...... 19-directed CAR T-cell therapy
@en
Persistence of long-lived plas ...... 9-directed CAR T-cell therapy.
@nl
prefLabel
Persistence of long-lived plas ...... 19-directed CAR T-cell therapy
@en
Persistence of long-lived plas ...... 9-directed CAR T-cell therapy.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Persistence of long-lived plas ...... 19-directed CAR T-cell therapy
@en
P2093
P2860
P304
P31
P356
10.1182/BLOOD-2016-01-694356
P407
P433
P478
P50
P577
P698
P932